Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Cannabinoids and Neuropsychiatric Disorders

Cannabinoids and Neuropsychiatric Disorders

Murillo-Rodriguez, Eric
Pandi-Perumal, S. R.
Monti, Jaime M.

Hardcover

Series: Advances in Experimental Medicine and Biology, Book 1264

Medical ReferenceBiology

ISBN10: 3030573680
ISBN13: 9783030573683
Publisher: Springer
Published: Dec 18 2020
Pages: 153
Weight: 1.14
Height: 0.44 Width: 7.00 Depth: 10.00
Language: English

This volume highlights the recent advances in the understanding of the endocannabinoid system and the likely benefit from the therapeutic effects of cannabinoid treatment in a variety of health issues.

Archeological evidence has shown that Cannabis has a long history of use for multiple purposes, including the treatment of medical conditions. The primary active constituent of the hemp plant Cannabis sativa, delta 9-tetrahydrocannabinol (Δ9-THC), causes euphoria, enhancement of sensory perception, tachycardia, antinociception, difficulties in concentration and impairment of memory, among other effects. Despite these undesirable effects, signaling is mostly inhibitory and suggests a putative role for cannabinoids as therapeutic agents by managing several diseases where inhibition of neurotransmitter release would be beneficial.

Also in

Biology

View All